Results 291 to 300 of about 1,583,699 (313)

GHEARD: An Open-Access Modular Curriculum to Incorporate Equity, Anti-Racism, and Decolonization Training Into Global Health Education. [PDF]

J Grad Med Educ
Rule ARL, Haq HA, Barnes A, Bowen D, Chiume-Kayuni M, Cameron W, Fanny SA, Groothuis E, Hodge B, Howard C, Hudspeth JC, Langford S, McHenry MS, Opara IN, Kamath-Rayne BD, Suchdev PS, Tam RP, Taylor F, Musiime V.   +18 more
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Navigating the future: Ensuring quality research with open access. [PDF]

J Cutan Aesthet Surg
Arora S.
europepmc   +1 more source

MIF as an oncogenic driver of low‐heterogeneity melanomas

Molecular Oncology, EarlyView.
Shvefel and colleagues identified tumor‐secreted macrophage migration inhibitory factor (MIF) as an upregulated cytokine that mediates immune resistance in melanomas with low‐intratumoral heterogeneity. MIF and its functional paralogue D‐dopachrome tautomerase (D‐DT or MIF‐2) have overlapping but nonidentical signaling functions and are hypothesized to
Thuy T. Tran, Gabriela Athziri Sánchez‐Zuno, Rajan P. Kulkarni, Harriet M. Kluger, Richard Bucala   +4 more
wiley   +1 more source

Open Access in the Age of AI: The Journal of Appalachian Health and Hurricane Helene Recovery. [PDF]

J Appalach Health
Wren N, Firchow B.
europepmc   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

RefXAS: an open access database of X-ray absorption spectra. [PDF]

J Synchrotron Radiat
Paripsa S, Gaur A, Förste F, Doronkin DE, Malzer W, Schlesiger C, Kanngießer B, Welter E, Grunwaldt JD, Lützenkirchen-Hecht D.   +9 more
europepmc   +1 more source

An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates. [PDF]

Sci Rep
Phelan J, Van den Heede K, Masyn S, Verbeeck R, Clark TG, Lamprecht DA, Koul A, Wall RJ.   +7 more
europepmc   +1 more source

Open-Access-Suchmaschinen

, 2009
openaire   +3 more sources

Evaluation and Comparison of the Academic Quality of Open-Access Mega Journals and Authoritative Journals: Disruptive Innovation Evaluation.

J Med Internet Res
Jiang Y, Liu XL, Wang L.
europepmc   +1 more source